文献速递心力衰竭与心肌病

北非近亲婚配人群肥厚型心肌病的遗传结构

Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
PubMed 文献 · Eur Heart J · 2023-01-01

该前瞻性研究对514例埃及肥厚型心肌病(HCM)患者和400例对照进行临床表型与基因检测,并与684例欧洲裔HCM患者比较。埃及患者纯合变异患病率更高(4.1% vs. 0.1%,P=2×10⁻⁷),TRIM63双等位基因变异占2.1%(为欧洲患者的5倍),且罕见变异被分类为(可能)致病的比例更低(40.8% vs. 61.6%,P=1.6×10⁻⁵),引入 ancestry-matched 对照方法后该比例增至53.3%。

要点

  • 近亲婚配人群HCM中纯合变异比例显著高于欧洲裔人群。
  • 小HCM基因MYL2、MYL3、CSRP3的变异更易以纯合形式出现。
  • TRIM63双等位基因变异在埃及患者中占2.1%,提示隐性遗传重要性。

核心结论

  • 研究近亲婚配人群可揭示HCM遗传结构的新见解,对基因检测和疾病理解有重要意义。

研究设计与样本

  • 前瞻性纳入埃及HCM患者514例和对照400例,进行临床表型与基因检测。
  • 对13个经验证的HCM基因中的罕见变异按标准临床指南分类。
  • 与前瞻性欧洲裔为主HCM队列684例进行比较。

主要发现

  • 埃及患者纯合变异患病率为4.1%,欧洲裔患者为0.1%(P=2×10⁻⁷)。
  • MYL2、MYL3和CSRP3变异更易以纯合形式出现,提示杂合状态下外显率较低。
  • TRIM63双等位基因变异在埃及患者中占2.1%,为欧洲患者的5倍。
  • 埃及患者罕见变异被分类为(可能)致病的比例为40.8%,欧洲患者为61.6%(P=1.6×10⁻⁵)。
  • 采用 ancestry-matched 对照方法后,埃及患者该比例增至53.3%。

关键数值与推荐

  • 纯合变异患病率:埃及患者4.1% vs. 欧洲裔患者0.1%(P=2×10⁻⁷)。
  • TRIM63双等位基因变异:埃及患者2.1%,为欧洲患者的5倍。
  • (可能)致病性变异比例:埃及患者40.8% vs. 欧洲患者61.6%(P=1.6×10⁻⁵),方法改进后增至53.3%。

临床怎么用

  • 在近亲婚配人群中应关注隐性遗传模式及纯合变异。
  • 对MYL2、MYL3、CSRP3和TRIM63等基因应结合 ancestry-matched 对照进行变异解读。
  • 当前参考资源对中东人群代表性不足,需谨慎评估致病性分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity that is partly explained by the diversity of genetic variants contributing to disease. Accurate interpretation of these variants constitutes a major challenge for diagnosis and implementing precision medicine, especially in understudied populations. The aim is to define the genetic architecture of HCM in North African cohorts with high consanguinity using ancestry-matched cases and controls. METHODS AND RESULTS: Prospective Egyptian patients (n = 514) and controls (n = 400) underwent clinical phenotyping and genetic testing. Rare variants in 13 validated HCM genes were classified according to standard clinical guidelines and compared with a prospective HCM cohort of majority European ancestry (n = 684). A higher prevalence of homozygous variants was observed in Egyptian patients (4.1% vs. 0.1%, P = 2 × 10-7), with variants in the minor HCM genes MYL2, MYL3, and CSRP3 more likely to present in homozygosity than the major genes, suggesting these variants are less penetrant in heterozygosity. Biallelic variants in the recessive HCM gene TRIM63 were detected in 2.1% of patients (five-fold greater than European patients), highlighting the importance of recessive inheritance in consanguineous populations. Finally, rare variants in Egyptian HCM patients were less likely to be classified as (likely) pathogenic compared with Europeans (40.8% vs. 61.6%, P = 1.6 × 10-5) due to the underrepresentation of Middle Eastern populations in current reference resources. This proportion increased to 53.3% after incorporating methods that leverage new ancestry-matched controls presented here. CONCLUSION: Studying consanguineous populations reveals novel insights with relevance to genetic testing and our understanding of the genetic architecture of HCM.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Allouba M, Walsh R, Afify A, et al. Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy. Eur Heart J. 2023. PMID: 37431535. doi:10.1093/eurheartj/ehad372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。